AKT1 and leukemia: AKT inhibition is a successful strategy for reversing evasion mechanisms of cellular cancer and contributing to the elimination of leukemia cells via an natural Killer-mediated mechanism, which strongly advocates AKT as a molecular target in current and future combined treatments to improve immunotherapy outcomes.